XNW-34017

N/A

Report date: 2026/04/29 20:02:18
NMEFirst In Class

Base Information

Drug NameXNW-34017
Drug Alias NameXNW-34017XNW34017
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMyc proto-oncogene protein degradersSerine/threonine-protein kinase Aurora-A degraders
TargetsMyc proto-oncogene proteinSerine/threonine-protein kinase Aurora-A
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEvopoint Biosciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEvopoint Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A